Cancer risk among patients with systemic sclerosis: A nationwide population study in Taiwan

Scandinavian Journal of Rheumatology

Volumn 41, Issue 1, 2012, Pages 44-49

  Kuo, C F ^a,b   Luo, S F ^b,c   Yu, K H ^b,c   Chou, I J ^d   Tseng, W Y ^a,b   Chang, H C ^b   Fang, Y F ^b   Chiou, M J ^a,e   See, L C ^a,e  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^d CHANG GUNG CHILDREN S HOSPITAL   (Taiwan)

^e Molecular Medicine Research Centre   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD; BREAST; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER RISK; CONTROLLED STUDY; DISEASE REGISTRY; FEMALE; GASTROINTESTINAL TRACT; HAZARD RATIO; HEMATOLOGIC MALIGNANCY; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MORTALITY; MOUTH CANCER; PHARYNX CANCER; POPULATION RESEARCH; PRIORITY JOURNAL; STANDARDIZED INCIDENCE RATIO; SYSTEMIC SCLEROSIS; TAIWAN;

ADULT; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASMS; PHARYNGEAL NEOPLASMS; REGISTRIES; RISK FACTORS; SCLERODERMA, SYSTEMIC; TAIWAN;

EID: 84856501380     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.3109/03009742.2011.618145     Document Type: Article

References (32)

1. Karassa FB, Ioannidis JP. Mortality in systemic sclerosis. Clin Exp Rheumatol 2008;26:S85-93.
2. Ioannidis JP, Vlachoyiannopoulos PG, Haidich AB, Medsger TA Jr, Lucas M, Michet CJ, et al. Mortality in systemic sclerosis: an international meta-analysis of individual patient data. Am J Med 2005;118:2-10. (Pubitemid 40082450)
3. Kuo CF, See LC, Yu KH, Chou IJ, Tseng WY, Chang HC, et al. Epidemiology and mortality of systemic sclerosis: a nationwide population study in Taiwan. Scand J Rheumatol 2011, [Epub ahead of print], doi:10.3109/03009742.2011.553736.
4. Lee P, Alderdice C, Wilkinson S, Keystone EC, Urowitz MB, Gladman DD. Malignancy in progressive systemic sclerosis: association with breast carcinoma. J Rheumatol 1983;10:665-6.
5. Roumm AD, Medsger TA Jr. Cancer and systemic sclerosis. An epidemiologic study. Arthritis Rheum 1985;28:1336-40. (Pubitemid 16156143)
6. Young R, Towbin B, Isern R. Scleroderma and ovarian carcinoma. Br J Rheumatol 1990;29:314. (Pubitemid 20226554)
7. Peters-Golden M, Wise RA, Hochberg M, Stevens MB, Wigley FM. Incidence of lung cancer in systemic sclerosis. J Rheumatol1985;12:1136-9. (Pubitemid 16166459)
8. Wooten M. Systemic sclerosis and malignancy: a review of the literature. South Med J 2008;101:59-62.
9. Rosenthal AK, McLaughlin JK, Gridley G, Nyren O. Incidence of cancer among patients with systemic sclerosis. Cancer1995;765:910-14.
10. Rosenthal AK, McLaughlin JK, Linet MS, Persson I. Scleroderma and malignancy: an epidemiological study. Ann Rheum Dis 1993;52:531-3. (Pubitemid 23227219)
11. Olesen AB, Svaerke C, Farkas DK, Sorensen HT. Systemic sclerosis and the risk of cancer: a nationwide population-based cohort study. Br J Dermatol 2010;163:800-6.
12. Kanaji N, Fujita J, Bandoh S, Fukumoto T, Ishikawa M, Haba R, et al. Small cell lung cancer associated with systemic sclerosis. Intern Med 2005;44:315-18. (Pubitemid 40663034)
13. Scope A, Sadetzki S, Sidi Y, Barzilai A, Trau H, Kaufman B, et al. Breast cancer and scleroderma. SKINmed 2006;5:18-24.
14. Pineda V, Salvador R, Soriano J. Bilateral breast cancer associated with diffuse scleroderma. Breast 2003;12:217-19. (Pubitemid 36665521)
15. Siau K, Laversuch CJ, Creamer P, O'Rourke KP. Malignancy in scleroderma patients from South West England: a population-based cohort study. Rheumatol Int 2011;31:641-5.
16. Shah AA, Rosen A, Hummers L, Wigley F, Casciola-Rosen L. Close temporal relationship between onset of cancer and scleroderma in patients with RNA polymerase I/III antibodies. Arthritis Rheum 2010;62:2787-95.
17. Derk CT, Rasheed M, Artlett CM, Jimenez SA. A cohort study of cancer incidence in systemic sclerosis. J Rheumatol 2006;33:1113-16. (Pubitemid 43825461)
18. Hill CL, Nguyen AM, Roder D, Roberts-Thomson P. Risk of cancer in patients with scleroderma: a population based cohort study. Ann Rheum Dis 2003;62:728-31. (Pubitemid 36886406)
19. Hudson M, Thombs B, Baron M. Time to diagnosis in systemic sclerosis: is sex a factor? Arthritis Rheum 2009;61:274-8.
20. Kang KY, Yim HW, Kim IJ, Yoon JU, Ju JH, Kim HY, et al. Incidence of cancer among patients with systemic sclerosis in Korea: results from a single centre. Scand J Rheumatol 2009;38:299-303.
21. Derk CT, Sakkas LI, Rasheed M, Artlett C, Jimenez SA. Autoantibodies in patients with systemic sclerosis and cancer: a case-control study. J Rheumatol 2003;30:1994-6. (Pubitemid 37075550)
22. Chatterjee S, Dombi GW, Severson RK, Mayes MD. Risk of malignancy in scleroderma: a population-based cohort study. Arthritis Rheum 2005;52:2415-24. (Pubitemid 41117427)
23. Derk CT, Rasheed M, Spiegel JR, Jimenez SA. Increased incidence of carcinoma of the tongue in patients with systemic sclerosis. J Rheumatol 2005;32:637-41. (Pubitemid 40524694)
24. Harrison BJ, Silman AJ, Hider SL, Herrick AL. Cigarette smoking as a significant risk factor for digital vascular disease in patients with systemic sclerosis. Arthritis Rheum 2002;46:3312-16. (Pubitemid 35453542)
25. Hudson M, Lo E, Lu Y, Hercz D, Baron M, Steele R; Canadian Scleroderma Research Group. Cigarette smoking in patients with systemic sclerosis. Arthritis Rheum 2010;63:230-8.
26. Derk CT. Associations of breast cancer development in patients with systemic sclerosis: an exploratory study. Clin Rheumatol 2007;26:1615-19.
27. Launay D, Le Berre R, Hatron PY, Peyrat JP, Hachulla E, Devulder B, et al. Association between systemic sclerosis and breast cancer: eight new cases and review of the literature. Clin Rheumatol 2004;23:516-22. (Pubitemid 39562258)
28. Lu TY, Hill CL, Pontifex EK, Roberts-Thomson PJ. Breast cancer and systemic sclerosis: a clinical description of 21 patients in a population-based cohort study. Rheumatol Int 2008;28:895-9.
29. Silman AJ. Scleroderma - demographics and survival. J Rheumatol Suppl 1997;48:58-61.
30. Czirjak L, Kumanovics G, Varju C, Nagy Z, Pakozdi A, Szekanecz Z, et al. Survival and causes of death in 366 Hungarian patients with systemic sclerosis. Ann Rheum Dis 2008;67:59-63.
31. Scussel-Lonzetti L, Joyal F, Raynauld JP, Roussin A, Rich E, Goulet JR, et al. Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine (Baltimore) 2002;81:154-67. (Pubitemid 34218570)
32. Hsu HY, Chang MH, Chen DS, Lee CY, Sung JL. Baseline seroepidemiology of hepatitis B virus infection in children in Taipei, 1984: a study just before mass hepatitis B vaccination program in Taiwan. J Med Virol 1986;18:301-7.